AIIMS Qualified Dermatologist | Board Certified Hair Transplant Surgeons (GHTB) | Members of ISHRS (USA)

  For Hair +91-8882227080

  For Skin +91-8588829376

HD-PRP Therapy

Biologic Therapy for Urticaria & Atopic Dermatitis (Eczema)

When antihistamines or topical care aren’t enough, biologic therapy offers a precise, evidence-based option

MAsk

Biologic Therapy for Urticaria & Atopic Dermatitis (Eczema)

Targeted medicines, dermatologist-led. When antihistamines or topical care aren't enough, biologic therapy offers a precise, evidence-based option—designed to calm the overactive immune pathways behind chronic hives and moderate-to-severe eczema. At Dermaclinix (Defence Colony, South Delhi), our AIIMS-trained dermatologists recommend biologics only when truly indicated, after a clear diagnosis and stepwise care.

Biologics for Chronic Urticaria (Hives)

What it treats:

Chronic spontaneous urticaria (CSU)

Growth factors act like text messages to hair-root cells (dChronic spontaneous urticaria (CSU)—hives on most days for ≥6 weeks, sometimes with angioedema.ermal papilla).

Inducible urticarias

Select inducible urticarias (pressure, cold, cholinergic) when conventional therapy fails.

The standard biologic: Omalizumab (anti-IgE)

How it works:

Binds free IgE and down-regulates IgE receptors on mast cells over weeks, helping reduce wheals and itch.

How it’s given: 150 mg or 300 mg

How it’s given: 150 mg or 300 mg as a subcutaneous injection every 4 weeks; many patients respond after 2–4 doses. Monitoring is done in-clinic.

If control is incomplete

If control is incomplete: specialist-guided dose/interval escalation may be considered under international urticaria guidelines; allow up to 6 months to judge response.

Your dermatologist will screen for contraindications, discuss rare risks (including anaphylaxis), and provide a clear action plan

Book An Appointment

Biologics for Atopic Dermatitis (Eczema)fits

When we consider a biologic:

Moderate-to-severe AD not controlled with optimized moisturizers, topical anti-inflammatories, and (where appropriate) phototherapy

Related (not biologics, but targeted):

JAK inhibitors (e.g., upadacitinib, abrocitinib) are oral, rapid-acting options for selected patients when biologics aren’t suitable; require lab and safety monitoring.

Options we use and discuss:

Dupilumab (IL-4/IL-13 pathway): improves inflammation and itch; suitable for adults and adolescents per major guidelines; long-term data support sustained benefit and acceptable safety. Pairs well with standard medical hair treatment plans

Tralokinumab (IL-13): an alternative for moderate-to-severe AD; guideline-supported efficacy and safety.

Who is a good candidate?
  • Urticaria: symptoms ≥6 weeks despite optimized second-generation antihistamines (including step-up dosing); significant impact on sleep/work; no red-flag contraindications.
  • Atopic dermatitis: moderate–severe disease despite optimized topical care; frequent flares, disturbed sleep, or widespread involvement; discussion of biologic vs targeted oral options.
MAsk

Dermaclinix approach: diagnosis first → optimize basics → biologic only when indicated → review milestones every 8–12 weeks.

Safety & monitoring (what we do)
  • Pre-treatment review (history, triggers, vaccines),
    rule-outs, and counseling.
  • In-clinic initiation with post-injection observation
    when required; clear contact pathway for any
    concerns.
  • Ongoing assessment of response, comfort, and side
    effects; adjust plan (add/step down) to keep therapy
    minimal but effective.
saifty-img
saifty-img
Timelines & follow-up
  • Omalizumab (CSU): first check at 4–8 weeks,
    continue up to 6 months to determine response;
    then taper or maintain as advised.
  • Dupilumab/Tralokinumab (AD): early itch relief often
    in 2–4 weeks; best skin clearance builds over 3–6
    monthswith steady use.

Google-Centric FAQs (Biologics)

They control disease by calming the pathways that drive hives/eczema. Many patients maintain excellent control while on therapy and can step down later under supervision. (Wiley Online Library, jaad.org)
For CSU, some feel better after the first–second omalizumab dose; a fair trial is up to 6 months. For AD, itch often improves within 2–4 weeks, with skin clearance over 3–6 months. (jacionline.org , jaad.org)
No. Biologics are targeted to specific immune signals (e.g., IgE, IL-4/IL-13), not broad steroids. They’re used when standard care isn’t enough and require specialist oversight. (jaad.org)
Yes. We keep barrier repair and gentle topicals in place; biologics reduce inflammation so skin can heal and flares decrease. (jaad.org)
We consider targeted oral options (JAK inhibitors) or adjust phototherapy/topicals. Your dermatologist will match benefits and risks to your health profile. ( jaad.org, PMC)

Results

Before
After
Check out the Drastic changes!

Get Healthy Scalp like never before - See the result for your self !

Hair Regeneration Testimonials
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
YouTube Video
shorts
Recent Blogs

What Is a True NoShave FUE Hair Transplant? In traditional FUE, small patches of the donor area ....

blog

“I wanted to fix my thinning hair—but I couldn’t imagine shaving it all off. Then I discovered unshaven....

blog

“I wanted to keep every strand of my hair—and I did. I walked in, walked out, and now.....

Book A Consultation
Take the first step toward thicker, stronger, naturally regrown hair.
Featured in
Forbes
TOI
CNN
India TV
Dainik Bhaskar
HT
Times Now
Forbes
TOI
CNN
India TV
Dainik Bhaskar
HT
Times Now
Get Appointment
Chat with us